Galderma Q3 Sales Climb; Raises FY26 Sales Growth Outlook
Galderma reported third-quarter sales of $1.63 billion and raised its sales growth outlook while confirming its FY26 core EBITDA margin view.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.